{{ 'fb_in_app_browser_popup.desc' | translate }} {{ 'fb_in_app_browser_popup.copy_link' | translate }}

{{ 'in_app_browser_popup.desc' | translate }}

21-valent Pneumococcal Conjugate Vaccine (PCV21) x 1 dose

21-valent Pneumococcal Conjugate Vaccine (PCV21) x 1 dose

Suitable for 18 years old or above


HK$2,200.00
Quantity Product set quantity
Add to Wishlist
The maximum quantity per submit is 99999
This quantity is invalid, please enter a valid quantity.
Sold Out

Not enough stock.
Your item was not added to your cart.

Not enough stock.
Please adjust your quantity.

{{'products.quick_cart.out_of_number_hint'| translate}}

{{'product.preorder_limit.hint'| translate}}

Limit {{ product.max_order_quantity }} per order.

Only {{ quantityOfStock }} item(s) left.

Please message the shop owner for order details.
Add to Wishlist
Description
Shipping & Payment
Customer Reviews
Description

【21-valentPneumococcal Conjugate Vaccine (PCV21)】1 dose (Suitable for 18 years old or above)


Adults aged 18 or above: 1 Dose


Product Description

【Next-Gen Vaccine Now Available! Lifetime Protection with Just 1 Dose】


The latest generation 21-valent pneumococcal conjugate vaccine (PCV21, CAPVAXIVE®) is developed by MSD (Merck & Co., Inc.) and specifically tailored for the prevention of invasive pneumococcal disease (IPD) in adults.

Featuring an all-new formulation, it precisely incorporates 8 new serotypes that predominantly affect adults, providing a more comprehensive and long-lasting barrier for your and your family's respiratory health.


🌟 3 Key Highlights of the Vaccine

  1. Specially Designed for Adult High-Risk Serotypes: Based on the latest adult epidemiological data, 8 new adult high-risk serotypes have been precisely added to deliver protection best suited for adult needs.
  2. Significantly Enhanced Protection Coverage: According to US FDA approval data, PCV21 covers approximately 82% of strains causing invasive pneumococcal disease in adults aged 50 or above, offering protection coverage significantly superior to traditional older vaccines.
  3. Single Dose for Long-Lasting Immunity: Utilizing "Pneumococcal Conjugate (PCV)" technology, it stimulates the immune system to build long-term immune memory with protection lasting over 10 years. For most adults, only 1 dose is needed in a lifetime.


🩺 Recommended Target Groups

This vaccine is approved for adults aged 18 or above, and is strongly recommended for the following high-risk groups:

  • Seniors and mature adults aged 50 or above (immunity gradually declines with age)
  • Individuals with chronic conditions (such as diabetes, chronic heart disease, chronic lung disease, and kidney disease)
  • Individuals with immunocompromising conditions or higher susceptibility to infections
  • Individuals with regular smoking or alcohol consumption habits




  • If assessed as unfit for vaccination, a HKD $200 consultation fee applies, and the remaining amount will be refunded.

  • Payment confirms acceptance of the [Booking Process] and [Terms of Use]; failure to comply may result in service termination. Kinetics Medical & Health Group reserves all final decisions.

  • Shipping & Payment

    Delivery Options

    • Kinetics Integrated Medical & Health Centre (Jordan)
    • Kinetics Integrated Medical & Health Centre (Causeway Bay)
    • Kinetics Integrated Medical & Health Centre (Tsuen Wan)
    • Kinetics Integrated Medical & Health Centre (By appointment)

    Payment Options

    • Apple Pay
    • Credit Card (Visa/Master/Union Pay/Diner Club)
    • Alipay (HK)_SHOPLINE Payments
    • WeChat Pay
    • Payme
    Customer Reviews
    {{'product.product_review.no_review' | translate}}

    You might also like...